ArticleJournal of food and drug analysis2025

Evaluating the cost-effectiveness of atezolizumab-bevacizumab in advanced hepatocellular carcinoma: Insights from Taiwan.

Tsung-Wei Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.